Safety of Nifedipine GITS in Stable Angina: The ACTION Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of Nifedipine GITS in Stable Angina: The ACTION Trial

Published:2006-02 Issue:1 Volume:20 Page:45-54
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Poole-Wilson Philip A., ,Kirwan Bridget-Anne,Vokó Zoltán,de Brouwer Sophie,van Dalen Fred J.,Lubsen Jacobus

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10557-006-6312-4.pdf

Reference44 articles.

1. Lenfant C. The calcium channel blocker scare. Lessons for the future. Circulation 1995;91:2855–2856.

2. Opie LH, Messerli FH. Nifedipine and mortality. Grave defects in the dossier. Circulation 1995;92:1068–1073.

3. Opie LH. Risks and benefits of calcium antagonists. Lancet 1995;346:961.

4. Horton R. Spinning the risks and benefits of calcium antagonists. Lancet 1995;346:586–587.

5. Poole-Wilson PA. The calcium antagonist controversy; implications beyond drug prescription. Eur Heart J 1996;17:1131–1133.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-hypertensive medications and erectile dysfunction: focus on β-blockers;Endocrine;2024-09-13

2. The use of specific antihypertensive medication and skin cancer risk: A systematic review of the literature and meta-analysis;Vascular Pharmacology;2023-06

3. The Risk for Prostate Cancer With Calcium Channel Blockers: A Systematic Review, Meta-Analysis, and Meta-Regression;Annals of Pharmacotherapy;2022-05-28

4. Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker;PLOS ONE;2021-11-18

5. Efficacy and safety outcomes of one generic nifedipine versus ADALAT long‐acting nifedipine for hypertension management;The Journal of Clinical Hypertension;2020-10-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3